The Dales Report | Trade to Black

On our latest Trade to Black podcast, Josh Schiller, an experienced trial lawyer from Boies Schiller Flexner LLP, provides updates from last week's oral argument in the David Boies lawsuit, which challenges the federal government's outdated marijuana regulations. During the oral arguments at the U.S. Court of Appeals for the First Circuit, the plaintiffs argued that the 2005 Gonzales v. Raich deci...

On our latest TDR Small Sunday Podcast, host Shadd Dales and TDR lead analyst Bill McFarland will break down 13 small-cap and micro-cap companies focusing on the Crypto industry. With Bitcoin eclipsing $100,000 last week and investor interest at an all-time high, we will discuss how the industry will trend in 2025. Donald Trump and his new administration are eager to pass a Crypto Bill once they e...

On our latest Trade To Black podcast, Beena Goldenberg, CEO of Organigram (Nasdaq: OGI), joins us to discuss the company’s acquisition of Motif, which will cement them as the #1 LP in Canada from a total market share perspective. We will also be covering the hot hemp ban of our Lt. Governor Dan Patrick's office in Texas. The NFL is lowering their standards for drug testing for cannabis in the best...

Cannabis Advisor Seth Yakatan joins Shadd Dales and Anthony Varrell for his weekly segment, which dives into cannabis data and trends you may not be aware of. First up: Pennsylvania, a huge catalyst state for major players like Trulieve, Green Thumb Industries, Curaleaf, and Verano. With Trulieve leading the footprint race with 21 stores, Pennsylvania’s medical market is thriving. But will legisla...

On our latest Trade To Black podcast, Host Shadd Dales & Anthony Varrell will break down the key takeaways from today’s ALJ hearing on the rescheduling of cannabis. The Drug Enforcement Administration (DEA) has officially begun its first hearing on the Biden administration’s proposal to move cannabis from Schedule I to Schedule III of the Controlled Substances Act. While today’s meeting is lar...

With the US Election, there has been a renewed interest in psychedelic stocks, driven by RFK Jr.’s recent comments on psychedelic research and his strong critique of the pharmaceutical industry, labeling America as one of the sickest countries in the world. This renewed focus has placed a spotlight on the psychedelic industry, which is conducting critical mental health trials to address conditions...

Happy Friday, everyone! Melissa Lavasani, CEO of Psychedelic Medicine, the leading psychedelics lobbyist firm, along with former Top Gun Fighter Pilot Matthew “Whiz” Buckley will join us. Topic of conversation? Psychedelic predictions for 2025. With Robert F. Kennedy Jr.’s recent endorsement of psychedelic research and his role as head of Health and Human Services (HHS), Lavasani will discuss her...

On our latest Trade To Black podcast, Shadd and Anthony discuss why the U.S. Department of Health and Human Services (HHS) rejected a request from the DEA to provide witnesses for the upcoming ALJ hearing on December 2, 2024, in Arlington, Virginia, concerning the rescheduling of cannabis. As reported by Marijuana Moment, HHS—responsible for conducting the scientific review that led to the resched...

On our latest Trade To Black podcast, hosts Shadd Dales and Anthony Varrell are joined by Michael Bronstein from ATACH. We will be covering the state by state bans we are starting to see and the prospects for what the language can look like in 2025 as it relates to the impending Farm Bill update. We have also seen some major headlines from NJ as it relates to insurance coverage as well as some gui...

Cybin (NYSE:CYBN) CEO Doug Drysdale, discusses the company’s groundbreaking results announced on Monday, November 18th. The key talking points included Cybin’s Phase 2 study of CYB003, a next-generation treatment for major depressive disorder (MDD). The study revealed extraordinary 12-month efficacy data, including 100% response rates and 71% remission among participants after just two 16 mg doses...

On our latest Trade To Black podcast, hosts Shadd Dales and Anthony Varrell break down some of the pressing headlines from this week. In the last few days we have seen Donald Trump's AG nominee flip from Matt Gaetz to Pam Bondi, Chuck Schumer dig up SAFE Banking to potentially get it done in the lame duck, SAM gets slapped for misbehaving, and Texas AG Ken Paxton is back on the prohibition train....

We talk Canada featuring a panel of Canadian executives sharing their insights on the future of the Canadian cannabis landscape. Emma Andrews, CEO of Nextleaf Solutions (CSE: OILS), Michael Perron, CEO of MTL Cannabis (CSE: MTLC), and Omar Khan, Chief Communications Officer of High Tide (NASDAQ: HITI), will discuss the biggest opportunities for Canadian companies heading into 2025 and why more com...

On our latest Trade To Black podcast, South Carolina Congresswoman Nancy Mace joins us to discuss cannabis reform and why she feels confident that progress can be made, based on recent appointee announcements by the Trump administration last week. In a tweet on X four days ago, Mace posted: “Three years ago, we shook up Congress with the States Reform Act – common-sense cannabis reform. Now, with...

Cybin (NYSE:CYBN) CEO Doug Drysdale will join us to discuss their latest trials, where they reported a 71% remission rate in patients with major depressive disorder (MDD) for their leading compound, CYB003. We’ll ask what’s next regarding their Phase III trial and the performance of the psychedelic stock. Plus, money is moving in the cannabis industry. Cory Azzalino, CEO of Eaze, will join us to h...

With the US Election, there has been a renewed interest in Psychedelic Stocks. This episode is going to be a special Small Cap Sunday Show. We will examine some psychedelic companies and establish a framework of analysis. Some investors have been very disappointed in the past, but Bill and Shadd are going to take a renewed look at the Psychedelic Sector. We will break from our normal format for th...

Anthony Coniglio, CEO of NewLake Capital (OTC: NLCP), will join us to discuss the company’s latest earnings. Unlike many cannabis stocks in 2024, NewLake Capital has performed strongly year-to-date, with the stock up over 20%. Well learn whether this momentum can continue heading into 2025. Additionally, cannabis lobbyist Don Murphy will share his insights on some of this week’s appointments in Do...

David Klein, CEO of Canopy Growth (NASDAQ: CGC), joins us to discuss the latest earnings numbers for Q2 2025. The cannabis company reported a 32% revenue increase for its popular ancillary brand, Storz & Bickel. Additionally, medical cannabis sales revenue grew 16% in Canada and 12% in international markets. Net revenue was down 9% quarter-over-quarter, while margins improved across the board....

Michael DeGiglio, CEO of Village Farms (NASDAQ:VFF) joins us to talk about the companies latest earnings, and explains how the cannabis segment saw a 29% year-over-year growth in total net sales. Some of the other notable highlights from their earnings included international medical cannabis sales doubling year over year, with significant growth in Germany, Australia, and the UK. Plus, earlier tod...

In a special edition of our Trade To Black podcast, Ascend Wellness (OTC: AAWH.U) President Frank Perullo will join us to discuss the latest earnings from the cannabis company. Highlights include $141.6 million in net revenue for Q3 2024, $25.1 million in Adjusted EBITDA, and an anticipated $30 million in annual savings through transformation initiatives. Plus, we dive into recent news involving f...

Today former Nikki Haley strategic advisor Rick Wiley joins us to share his views on how the Trump administration may handle cannabis reform. He will outline the approach for passing legislation in Congress and how to leverage campaigns to accomplish these goals. Plus, Dan Ahrens from Advisorshares (NYSEARCA:MSOS) will join us to talk about recent price action involving cannabis stocks and how he'...

In our latest Small Cap Sunday, co-hosts Shadd Dale and Bill McNarland will consider an analytic process to decide whether small-cap stocks with a long history of consistent dividends are worth buying. We call these stocks dividend aristocrats, and they have been paying dividends for over ten years through good and bad times. We will examine their business model and financial statements to determi...

Charlie Bachtell, CEO of Cresco Labs (OTC: CRLBF), joins us to discuss their latest earnings. We’ll also get his perspective on what’s next for the Florida market based on news from earlier this week about Amendment 3 not passing. Plus, United States Cannabis Council SVP David Culver will join us once again to discuss the future of the cannabis industry now that Donald Trump has won the election a...

We continue our coverage of the latest earnings reports from two of the largest MSOs in the cannabis industry. First up is Curaleaf (OTC:CURLF), with CEO Boris Jordan. He will discuss their latest numbers, highlight key successes from the past quarter, and address some of the challenges and trends the company anticipates heading into 2025. Following Curaleaf, TerrAscend (TSX:TSND) Chairman Jason W...

Earnings season for the cannabis industry is officially underway, beginning with MariMed Inc. (CSE:MRMD) CFO Mario Pinho and CRO Ryan Crandall join us talk in-depth on their latest numbers and an overview of their recent earnings, offering a high-level view of the quarter and what’s next. We’ll dive into investments too, learning about the new facilities they opened this year and how they’re perfo...

In our latest Trade To Black Podcast, we dive into the election results from yesterday, and what a Donald Trump presidency will mean for the cannabis industry moving forward. Cannabis lobbyist Don Murphy will join us to shed light on what happened last night in Florida and why Amendment 3 did not pass. Plus, with Republicans regaining control of the Senate, Murphy will explain on what's next for R...